Eve A Roberts1,2,3. 1. Paediatrics, Medicine, and Pharmacology & Toxicology, University of Toronto, Toronto, Canada. eve.roberts@sickkids.ca. 2. History of Science and Technology Programme, University of King's College, Halifax, NS, USA. eve.roberts@sickkids.ca. 3. Division of Gastroenterology, Hepatology, and Nutrition, The Hospital for Sick Children, Room 8258, Black Wing, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada. eve.roberts@sickkids.ca.
Abstract
PURPOSE OF REVIEW: Exciting developments relating to Wilson disease (WD) have taken place with respect to both basic biological and clinical research. This review critically examines some of these findings and considers their implications for current thinking about WD. It is not a comprehensive review of WD as a clinical disorder. RECENT FINDINGS: The structure of the gene product of ATP7B, abnormal in WD, is being worked out in detail, along with a broader description of how the protein ATP7B (Wilson ATPase) functions in cells including enterocytes, not only in relation to copper disposition but also to lipid synthesis. Recent population studies raise the possibility that WD displays incomplete penetrance. Innovative screening techniques may increase ascertainment. New strategies for diagnosing and treating WD are being developed. Several disorders have been identified which might qualify as WD-mimics. WD can be difficult to diagnose and treat. Insights from its pathobiology are providing new options for managing WD.
PURPOSE OF REVIEW: Exciting developments relating to Wilson disease (WD) have taken place with respect to both basic biological and clinical research. This review critically examines some of these findings and considers their implications for current thinking about WD. It is not a comprehensive review of WD as a clinical disorder. RECENT FINDINGS: The structure of the gene product of ATP7B, abnormal in WD, is being worked out in detail, along with a broader description of how the protein ATP7B (WilsonATPase) functions in cells including enterocytes, not only in relation to copper disposition but also to lipid synthesis. Recent population studies raise the possibility that WD displays incomplete penetrance. Innovative screening techniques may increase ascertainment. New strategies for diagnosing and treating WD are being developed. Several disorders have been identified which might qualify as WD-mimics. WD can be difficult to diagnose and treat. Insights from its pathobiology are providing new options for managing WD.
Entities:
Keywords:
ATP7B; Bis-choline tetrathiomolybdate; Copper; D-penicillamine; Drug-pricing; Hepatic; Hepatolenticular degeneration; Methanobactin; Neurological; Psychiatric; Trientine; Wilson ATPase; Wilson disease; Zinc salts
Authors: Helly R Goez; Francois D Jacob; Robert D Fealey; Marc C Patterson; Vijay Ramaswamy; Rabin Persad; Edward S Johnson; Jerome Y Yager Journal: J Child Neurol Date: 2011-01-27 Impact factor: 1.987
Authors: Andrew Duncan; Calum Yacoubian; Robert Beetham; Anthony Catchpole; David Bullock Journal: Ann Clin Biochem Date: 2016-10-13 Impact factor: 2.057
Authors: Ryan McDaniell; Daniel M Warthen; Pedro A Sanchez-Lara; Athma Pai; Ian D Krantz; David A Piccoli; Nancy B Spinner Journal: Am J Hum Genet Date: 2006-05-10 Impact factor: 11.025
Authors: Anna Wiernicka; Wojciech Jańczyk; Maciej Dądalski; Yesim Avsar; Hartmut Schmidt; Piotr Socha Journal: World J Gastroenterol Date: 2013-07-21 Impact factor: 5.742
Authors: Nathaniel H O Harder; Bettina Hieronimus; Kimber L Stanhope; Noreene M Shibata; Vivien Lee; Marinelle V Nunez; Nancy L Keim; Andrew Bremer; Peter J Havel; Marie C Heffern; Valentina Medici Journal: Nutrients Date: 2020-08-25 Impact factor: 5.717